unknown
Stage
About
Wiseneuro is a startup founded in 2021 as a spin-off of the Italian Institute of Technology in Genoa developing drugs for neurological diseases, including treatments targeting symptoms associated with Down syndrome, autism spectrum disorders, epilepsy, and rare neurodevelopmental diseases.
Explore Wiseneuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.